Notable Mover: Institutional Investors Are Dumping Cardinal Health Inc (NYSE:CAH)

November 25, 2016 - By Clifton Ray   ·   0 Comments

Notable Mover: Institutional Investors Are Dumping Cardinal Health Inc (NYSE:CAH)

Sentiment for Cardinal Health Inc (NYSE:CAH)

Cardinal Health Inc (NYSE:CAH) institutional sentiment decreased to 0.79 in Q2 2016. Its down -0.19, from 0.98 in 2016Q1. The ratio dived, as 319 investment managers increased and opened new positions, while 327 sold and decreased equity positions in Cardinal Health Inc. The investment managers in our partner’s database now possess: 267.07 million shares, down from 276.39 million shares in 2016Q1. Also, the number of investment managers holding Cardinal Health Inc in their top 10 positions decreased from 11 to 7 for a decrease of 4. Sold All: 60 Reduced: 267 Increased: 263 New Position: 56.

Cardinal Health, Inc. is a healthcare services and products company. The company has a market cap of $22.80 billion. The Firm operates through two divisions: Pharmaceutical and Medical. It has a 17.18 P/E ratio. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products.

About 179,726 shares traded hands. Cardinal Health Inc (NYSE:CAH) has declined 18.82% since April 22, 2016 and is downtrending. It has underperformed by 24.23% the S&P500.

Analysts await Cardinal Health Inc (NYSE:CAH) to report earnings on February, 6. They expect $1.26 earnings per share, down 3.08% or $0.04 from last year’s $1.3 per share. CAH’s profit will be $405.66 million for 14.06 P/E if the $1.26 EPS becomes a reality. After $1.24 actual earnings per share reported by Cardinal Health Inc for the previous quarter, Wall Street now forecasts 1.61% EPS growth.

According to Zacks Investment Research, “Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services and Automation and Information Services.”

Dsc Advisors L.P. holds 8.85% of its portfolio in Cardinal Health Inc for 180,237 shares. Sio Capital Management Llc owns 170,404 shares or 6.79% of their US portfolio. Moreover, Healthinvest Partners Ab has 5.72% invested in the company for 160,000 shares. The California-based Mcdonald Capital Investors Inc Ca has invested 5.7% in the stock. Rr Partners Lp, a New York-based fund reported 1.41 million shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider purchases, and 7 sales for $50.79 million net activity.

Cardinal Health Inc (NYSE:CAH) Ratings Coverage

Ratings analysis reveals 30% of Cardinal Health’s analysts are positive. Out of 10 Wall Street analysts rating Cardinal Health, 3 give it “Buy”, 0 “Sell” rating, while 7 recommend “Hold”. The lowest target is $82 while the high is $107. The stock’s average target of $92.13 is 30.09% above today’s ($70.82) share price. CAH was included in 19 notes of analysts from August 10, 2015. The stock of Cardinal Health Inc (NYSE:CAH) earned “Conviction Buy” rating by Goldman Sachs on Monday, March 7. The firm earned “Market Perform” rating on Tuesday, March 15 by Cowen & Co. UBS initiated the shares of CAH in a report on Thursday, October 6 with “Neutral” rating. The firm earned “Market Perform” rating on Wednesday, January 6 by Raymond James. The stock of Cardinal Health Inc (NYSE:CAH) has “Buy” rating given on Thursday, December 17 by Goldman Sachs. On Wednesday, August 26 the stock rating was maintained by William Blair with “Buy”. The stock has “Buy” rating given by Zacks on Monday, August 10. The rating was downgraded by Robert W. Baird to “Neutral” on Friday, October 28. As per Tuesday, November 3, the company rating was maintained by FBR Capital. As per Thursday, August 4, the company rating was maintained by Deutsche Bank.

CAH Company Profile

Cardinal Health, Inc. is a healthcare services and products company. The Firm operates through two divisions: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also makes, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

More notable recent Cardinal Health Inc (NYSE:CAH) news were published by: Nasdaq.com which released: “Cardinal Health to Acquire Lymphoseek Rights for $80 Million” on November 25, 2016, also Businesswire.com with their article: “Navidea Signs Asset Purchase Agreement with Cardinal Health” published on November 23, 2016, Investorplace.com published: “Cardinal Health Inc (CAH) Stock Looks Healthy in the Long Term” on November 21, 2016. More interesting news about Cardinal Health Inc (NYSE:CAH) were released by: Wsj.com and their article: “Cardinal Health Cuts Profit Guidance” published on October 31, 2016 as well as Forbes.com‘s news article titled: “Cardinal Health Enters Oversold Territory” with publication date: October 28, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>